![Patrick Weiss](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrick Weiss
Directeur/Membre du Conseil chez
Scale Biosciences, Inc.
Profil
Patrick Weiss joined ARCH as a Venture Partner in 2022.
In this capacity Patrick is focused on identifying and evaluating new breakthrough life science technologies.
He also assists in creating, scaling and operating ARCH portfolio companies.
Patrick joins ARCH from Twist Bioscience, a company providing synthetic DNA-based products based on a disruptive and proprietary technology, including synthetic genes, tools for NGS sample preparation, and antibody libraries for drug discovery and development.
During his tenure as COO, he played a pivotal role in navigating Twist from a small pre–Series A start-up to a successful publicly traded company.
Prior to Twist he was the CEO of Operon Biotechnologies, a global leader in nucleic acid synthesis, sequencing and bio-informatics services, Vice President Gene silencing at Qiagen responsible for its RNA synthesis and siRNA product portfolio and Founder and CEO of Xeragon Inc., a global leader in RNA synthesis and related products.
He currently serves on the board of Slingshot Biosciences and Scale Biosciences.
Patrick holds a MSc ETH from the Swiss Federal Institute of Technology in Organic Chemistry and Economics and is inventor on several patents and publications in the field of nucleic acid synthesis and related fields.
Postes actifs de Patrick Weiss
| Sociétés | Poste | Début |
|---|---|---|
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Private Equity Investor | 01/11/2022 |
Slingshot Biosciences, Inc.
 Slingshot Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research services | Directeur/Membre du Conseil | 01/04/2022 |
Scale Biosciences, Inc.
 Scale Biosciences, Inc. Medical SpecialtiesHealth Technology Develops single cell sequencing library preparation technology and single-cell analysis solutions | Directeur/Membre du Conseil | - |
Anciens postes connus de Patrick Weiss
| Sociétés | Poste | Fin |
|---|---|---|
| TWIST BIOSCIENCE CORPORATION | Directeur des opérations | 21/04/2022 |
Eurofins Genomics LLC
 Eurofins Genomics LLC Pharmaceuticals: MajorHealth Technology Offers a wide and comprehensive range of high-quality oligos, probes, and primers, as well as custom synthesis including a full range of longmers and modified oligos | Directeur Général | 01/03/2010 |
Qiagen, Inc.
 Qiagen, Inc. Miscellaneous Commercial ServicesCommercial Services Provides technologies for separating, purifying and handling nucleic acids | Fondateur | 01/06/2004 |
Xeragon, Inc.
 Xeragon, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops DNA and RNA products | Fondateur | 01/04/2002 |
Formation de Patrick Weiss
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
44
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
Twist Bioscience Corp.
 Twist Bioscience Corp. BiotechnologyHealth Technology Manufactures, distributes and sells synthetic DNA products through online | Health Technology |
Xeragon, Inc.
Xeragon, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops DNA and RNA products | Commercial Services |
Swiss Federal Institute of Technology
 Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Qiagen, Inc.
Qiagen, Inc. Miscellaneous Commercial ServicesCommercial Services Provides technologies for separating, purifying and handling nucleic acids | Commercial Services |
Eurofins Genomics LLC
Eurofins Genomics LLC Pharmaceuticals: MajorHealth Technology Offers a wide and comprehensive range of high-quality oligos, probes, and primers, as well as custom synthesis including a full range of longmers and modified oligos | Health Technology |
Slingshot Biosciences, Inc.
Slingshot Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research services | Commercial Services |
Scale Biosciences, Inc.
Scale Biosciences, Inc. Medical SpecialtiesHealth Technology Develops single cell sequencing library preparation technology and single-cell analysis solutions | Health Technology |
